ABBV Total assets
Total assets at AbbVie fell to $134.0B in fiscal 2025, the lowest in the 5 years reported, from $135.2B in 2024.
Total assets, as filed.
SOURCE: us-gaap:Assets · EDGAR CompanyFacts · CIK 1551152 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
FY2025$134.0B
FY2024 $135.2B
HIGH$146.5B FY2021
LOW$134.0B FY2025
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Total assets | Change |
|---|---|---|
| FY2025 | $134.0B | $-1.2B |
| FY2024 | $135.2B | +$450M |
| FY2023 | $134.7B | $-4.1B |
| FY2022 | $138.8B | $-7.7B |
| FY2021 | $146.5B | — |
More SAME DATA, OTHER VIEWS
Total assets across coverage → · ABBV company view →
Revenue · Net income · Operating cash flow · Free cash flow · Capital expenditure · Cash & equivalents · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.